OTCBB:CNBX

Cannabics Pharma Stock Forecast

etoro logo Buy CNBX
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Aug 10, 2026

Should you buy CNBX stock?

Last updated:

Based on market data through , StockInvest.us rates Cannabics Pharma (CNBX) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation.

  • Hold signal since
  • Price since signal Flat 0.00%
  • 3-month trend forecast Down 51.00%
  • Hold/Accumulate 0.00
AI Analysis AI Analysis of CNBX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CNBX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in Cannabics Pharma stock price on Monday which ended trading at $0.0001
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Aug 10, 2026

No changes to the price of Cannabics Pharma stock on the last trading day (Monday, 10th Aug 2026). During the last trading day the stock fluctuated 50.00% from a day low at $0.0001 to a day high of $0.0002. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -51.00% during the next 3 months and, with a 90% probability hold a price between $0.00000148187785 and $0.00006901902472 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CNBX Signals & Forecast

There are mixed signals in the stock today. The Cannabics Pharma stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0001 and $0.0001. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Tuesday, July 07, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, July 07, 2026 and based on theory for this formation the price should go up by 80.00% to $0.0002 within 5 trading days (Tuesday, July 14, 2026) since signal was issued.

Support, Risk & Stop-loss for Cannabics Pharma stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.00005 between high and low, or 50.00%. For the last week, the stock has had daily average volatility of 10.00%.

Our recommended stop-loss: $0.000094 (-6.00%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 24 days ago.)

Trading Expectations (CNBX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Cannabics Pharma to open at $0.0001, and during the day (based on 14 day Average True Range), to move between $0.00008915150745 and $0.0001, which gives a possible trading interval of +/-$0.00002169698511 (+/-24.34%) up or down from last closing price. If Cannabics Pharma takes out the full calculated possible swing range there will be an estimated 24.34% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0001, some $0.00002 (20.00%) from the current price of $0.0001, our system finds the risk reward not very attractive.

Is Cannabics Pharma stock A Buy?

Cannabics Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.0001 ( 16.67%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CNBX Performance

Trading levels for CNBX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0002 66.67%
R2 0.0001 47.57%
R1 0.0001 35.77%
Price 0.0001
S1 0.00009756666667 -2.43%
S2 0.00008576666667 -14.23%
S3 0.00006666666667 -33.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0.0001 20.00%
Price 0.0001
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Cannabics Pharma Stock and on which exchange is it traded?
The symbol for Cannabics Pharma is CNBX and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Cannabics Pharma Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Cannabics Pharma (CNBX) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. This is an upgrade from Sell in the previous daily evaluation. Since the Hold signal began on Aug 10, 2026, the price has remained flat. The current 3-month trend forecast projects a fall of 51.00%.

How to buy Cannabics Pharma Stock?
Cannabics Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cannabics Pharma Stock.

What's the current price of Cannabics Pharma Stock?
As of the end of day on the Aug 10, 2026, the price of an Cannabics Pharma (CNBX) share was $0.0001.

What is the 52-week high and low for Cannabics Pharma Stock?
The 52-week high for Cannabics Pharma Stock is $0.0008 and the 52-week low is $0.0001000000.

What is the market capitalization of Cannabics Pharma Stock?
As of the Aug 10, 2026, the market capitalization of Cannabics Pharma is 9.251K.
Click to get the best stock tips daily for free!
ABOUT CANNABICS PHARMA
Cannabics Pharma
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal p...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE